$0.86
-0.05(-5.13%)
Mkt Cap $41M
$0.71
$14.15
52-Week Range
At A Glance
1
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.
2
Revenue is primarily driven by Swine Vaccines (44.2%) and Direct Sales Channel (37.1%).
3
Most recently: Current Report on Form 6-K (2026-02-23).
$41M
Market Cap
—
Revenue
—
Net Income
Employees278
Fundamentals
How The Business Makes Money
Revenue by Segment
Swine Vaccines44.2%($582M)
Direct Sales Channel37.1%($489M)
Distribution Network11.9%($157M)
Poultry Vaccines3.6%($47M)
Other Vaccines2.2%($29M)
Government Tender And Procurement0.9%($12M)
Activity
Company Profile
CIK0001975641
ISINKYG989MS1016
CUSIPG989MS101
Phone86 432 6304 7008
AddressNo.1 Lianmeng Road, Jilin, 132101, CN
SEC EDGAR